APA (7th ed.) Citation

Papapetropoulos, A., Topouzis, S., Alexander, S. P. H., Cortese‐Krott, M., Kendall, D. A., Martemyanov, K. A., . . . Ferdinandy, P. (2024). Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review. British journal of pharmacology, 181(11), 1553-1575. https://doi.org/10.1111/bph.16337

Chicago Style (17th ed.) Citation

Papapetropoulos, Andreas, et al. "Novel Drugs Approved by the EMA, the FDA, and the MHRA in 2023: A Year in Review." British Journal of Pharmacology 181, no. 11 (2024): 1553-1575. https://doi.org/10.1111/bph.16337.

MLA (9th ed.) Citation

Papapetropoulos, Andreas, et al. "Novel Drugs Approved by the EMA, the FDA, and the MHRA in 2023: A Year in Review." British Journal of Pharmacology, vol. 181, no. 11, 2024, pp. 1553-1575, https://doi.org/10.1111/bph.16337.